Search Results - "Nano, Olger"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Folate Receptor Alpha-A Novel Approach to Cancer Therapy by Gonzalez, Teresita, Muminovic, Meri, Nano, Olger, Vulfovich, Michel

    “…Folate receptor α (FR) was discovered many decades ago, along with drugs that target intracellular folate metabolism, such as pemetrexed and methotrexate…”
    Get full text
    Journal Article
  2. 2

    Molecular Targeting of the Isocitrate Dehydrogenase Pathway and the Implications for Cancer Therapy by Ivanov, Stanislav, Nano, Olger, Hana, Caroline, Bonano-Rios, Amalia, Hussein, Atif

    “…The advent of comprehensive genomic profiling using next-generation sequencing (NGS) has unveiled an abundance of potentially actionable genetic aberrations…”
    Get full text
    Journal Article
  3. 3

    Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival by Thakral, Nimish, Gonzalez, Teresita, Nano, Olger, Shin, Sang-Ha, Samuels, Shenae, Hussein, Atif

    Published in BMC gastroenterology (13-05-2023)
    “…Cholangiocarcinoma (CCA), a malignancy of the biliary tract epithelium is of increasing importance due to its rising incidence worldwide. There is a lack of…”
    Get full text
    Journal Article
  4. 4

    Outcomes with bevacizumab for radiation induced-brain necrosis by Muminovic, Meri, Uribe, Carlos Carracedo, Dalal, Shivani, Castellon, Ignacio, Falchook, Aaron, Nano, Olger, Raez, Luis E.

    Published in Journal of clinical oncology (01-06-2023)
    “…e14006 Background: Radiation necrosis (RN) is post-radiation complication that leads to increased permeability and disruption of the blood brain barrier (BBB)…”
    Get full text
    Journal Article
  5. 5

    Vanishing Bile Duct Syndrome in a Patient With Recurrent Hodgkin Lymphoma by Nano, Olger, Ivanov, Stanislav, Kapoor, Tarun

    Published in Journal of medical cases (01-05-2023)
    “…Vanishing bile duct syndrome (VBDS) is an acquired syndrome characterized by clinical and laboratory signs of cholestasis with pathologic findings of…”
    Get full text
    Journal Article
  6. 6

    Extrahepatic cholangiocarcinoma versus intrahepatic cholangiocarcinoma: A comparison of survival outcomes and use of palliative care in diagnosed patients by Nimish, Thakral, Gonzalez, Teresita, Nano, Olger, Shin, Sang Ha, Samuels, Shenae, Hussein, Atif Mahmoud

    Published in Journal of clinical oncology (01-06-2022)
    “…e16192 Background: Cholangiocarcinoma (CCA), a malignancy of the biliary tract epithelium, is of increasing importance due to its rising incidence worldwide…”
    Get full text
    Journal Article
  7. 7

    A retrospective analysis of gender disparities in clinical outcomes of patients diagnosed with non-uterine leiomyosarcoma by Hana, Caroline, Nano, Olger, Samuels, Shenae, Hussein, Atif Mahmoud, Wadhawan, Ashna

    Published in Journal of clinical oncology (01-06-2022)
    “…e23547 Background: The effect of gender in sarcoma patients in various organ systems has been the subject of several studies, many of which show no overall…”
    Get full text
    Journal Article
  8. 8

    Evaluation of tumor gene expression profile (GEP) in minority patients with stage IV non-small cell lung cancer (NSCLC) by Villanueva, Matthew, Uribe, Carlos Carracedo, Brice, Kayla, Dumais, Katerine, Nano, Olger, Rodriguez, Mitchelle, Osmon, Elizabeth, Raez, Luis E.

    Published in Journal of clinical oncology (01-06-2022)
    “…e21043 Background: Differences in tumor gene expression profile (GEP) may contribute to disparities in lung cancer incidence and survival between racial and…”
    Get full text
    Journal Article